An accomplished McMaster University researcher has been selected for a new position in the Faculty of Health Sciences.
Paul Moayyedi has been named the inaugural assistant dean, research.
The assistant dean, research is primarily responsible for the operational management of selected biomedical and clinical research facilities, as well as for facilitating clinical investigations within the Faculty.
Moayyedi, a clinical scientist, is a professor in the Department of Medicine at McMaster. His five-year term as assistant dean, research started on July 1, 2018.
"It is an honour to be appointed as assistant dean of research," said Moayyedi. "I am excited to support clinical research in the most research intensive university in Canada."
He received his medical education at Bristol University, and trained in gastroenterology at Leeds' General Infirmary, UK. He was awarded a PhD and a Masters in Public Health from the University of Leeds.
Moayyedi was a professor of gastroenterology health services research at the University of Birmingham before coming to McMaster to serve as the inaugural Richard Hunt/AstraZeneca Chair of Gastroenterology in 2004. He has been the director of the division of gastroenterology and currently holds the Audrey Campbell Chair of Ulcerative Colitis Research.
He is a joint coordinating editor of the Upper Gastrointestinal and Pancreatic Diseases Cochrane Review Group.
His research interests focus on the microbiome ranging from population H. pylori screening and treatment to prevent gastric cancer, to fecal microbiota transplantation as a treatment of active ulcerative colitis.
He leads a CIHR Strategy for Patient Orientated Research funded consortium across Canada that evaluates the impact of diet and the microbiome on inflammatory bowel disease, irritable bowel syndrome and related psychiatric disorders."I am very excited to have Paul join the FHS Research Office," said Jonathan Bramson, vice-dean, research of the Faculty of Health Sciences. "His rich experience in translational research and his broad leadership expertise will be great addition to our team as we seek to expand our translational research capacity."